Skip to main content
Clinical Trials/CTRI/2023/02/049490
CTRI/2023/02/049490
Completed
Phase 3

A single blind clinical study to assess the efficacy of Viola Odorata in management of Chronic Bronchitis

Dr Ruchita Jerath0 sites30 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: J42- Unspecified chronic bronchitis
Sponsor
Dr Ruchita Jerath
Enrollment
30
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 7, 2023
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Ruchita Jerath

Eligibility Criteria

Inclusion Criteria

  • 1\. Those cases fulfilling the CBSS criteria and suffering is since 2 years or more.
  • 2\. Patients of All sexes will be included in the study.
  • 3\. Patients of 18 to 40 years age groups of various socio\-economic groups will be included.
  • 4\. Patient without any other systemic diseases.
  • 5\. Patient giving written consent form.
  • 6\. Patients coming under the case definition according to CBSS will be included.

Exclusion Criteria

  • 1\. That doesn’t fulfill CBSS criteria.
  • 2\. Cases with serious complication of Respiratory system and/or recently taking strong steroidal medication and having acute exacerbation of bronchitis.
  • 3\. Patients with Psychiatric diagnosis.
  • 4\. Pregnant and lactating women.
  • 5\. Malignancy cases.
  • 6\. Recent major surgery.
  • 7\. Immuno compromised cases.
  • 8\. Patients who have participated in any other Research study in last 6 months
  • 9\.Those under other medications for other diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials